67.17 F
New York
July 31, 2021

Biogen Inc

Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approval

CNBC
CNBC – For more and to sign up click here Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug.......

Biogen stock falls after FDA calls for federal investigation into Alzheimer’s drug approval

CNBC
CNBC – For more and to sign up click here A sign marks a Biogen facility, in Cambridge, Massachusetts, March 9, 2020. Brian Snyder | Reuters Biogen shares fell on Friday after the head of the Food and Drug Administration called for an investigation into the recent approval of the......

Stocks making the biggest moves in the premarket: Boeing, Intellia Therapeutics, Perion Network & more

CNBC
CNBC – For more and to sign up click here Take a look at some of the biggest movers in the premarket: Boeing (BA) – Boeing is not likely to receive certification for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a......

Patient receives first infusion of Biogen’s controversial Alzheimer’s drug

CNBC
CNBC – For more and to sign up click here The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images A 70-year-old man from Rhode Island on Wednesday was the first to receive an......

One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts

CNBC
CNBC – For more and to sign up click here As the Nasdaq hits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive the next leg of the rally. “The Nasdaq Composite broadly is breaking higher, and the key reason......

Stocks making the biggest moves midday: Chewy, Biogen, Snowflake and more

CNBC
CNBC – For more and to sign up click here Signage is seen ahead of the IPO for Chewy at the New York Stock Exchange, June 14, 2019. Andrew Kelly | Reuters Check out the companies making headlines in midday trading. Snowflake – Shares of the cloud computing company dropped......

Stocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy & more

CNBC
CNBC – For more and to sign up click here Take a look at some of the biggest movers in the premarket: Snowflake (SNOW) – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target......

Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

CNBC
CNBC – For more and to sign up click here A sign for the Food and Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Sarah Silbiger | Getty Images A third member of a key Food and Drug Administration advisory panel has......

Biogen’s Alzheimer’s drug could cost Medicare billions of dollars a year, report finds

CNBC
CNBC – For more and to sign up click here A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen‘s pricy new Alzheimer’s drug, Aduhelm, could cost Medicare billions of dollars a year, according to an analysis......

Stocks making the biggest moves midday: RH, Signet Jewelers, Clover & more

CNBC
CNBC – For more and to sign up click here Entrance of the Restoration Hardware store in the Meatpacking District of New York.  Source: RH RH – Shares of RH surged about 15% after the retailer’s first-quarter financial results beat Wall Street expectations. The home furnisher, known formerly as Restoration......

Dementia expert says evidence behind Biogen Alzheimer’s drug ‘wasn’t sufficient’ for FDA approval

CNBC
CNBC – For more and to sign up click here Dementia expert Dr. Jason Karlawish told CNBC he’s skeptical of the Food and Drug Administration’s approval of Biogen‘s Alzheimer’s disease drug, Aduhelm, saying “the evidence to approve the drug wasn’t sufficient.” “Another study is needed to establish whether this drug,......

Stock futures are flat after Dow starts week lower

CNBC
CNBC – For more and to sign up click here Traders on the floor of the New York Stock Exchange Source: NYSE Stock futures are flat in overnight trading Monday after the Dow and S&P 500 each started the week lower. Futures on the Dow Jones Industrial Average fell 18......

Stocks making the biggest moves after hours: Stitch Fix, Marvell, Coupa and more

CNBC
CNBC – For more and to sign up click here The Stitch Fix logo on a smartphone arranged in Hastings-on-Hudson, New York, U.S., on Saturday, June 5, 2021. Stitch Fix Inc. is scheduled to release earning on June 7. Tiffany Hagler-Geard | Bloomberg | Getty Images Check out the companies......

Biogen shares surge 60% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

CNBC
CNBC – For more and to sign up click here The Food and Drug Administration on Monday approved Biogen‘s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer’s and the first new medicine for the disease in......

Stocks making the biggest moves midday: AMC, Carnival and Eli Lilly

CNBC
CNBC – For more and to sign up click here An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters Check out the companies making headlines in midday trading. AMC Entertainment — The meme stock......

Stocks making the biggest moves in the premarket: G-III Apparel, U.S. Concrete, QTS Realty Trust & more

CNBC
CNBC – For more and to sign up click here Take a look at some of the biggest movers in the premarket: Amazon.com (AMZN) – CEO Jeff Bezos announced that he and his brother Mark will join an auction winner aboard the first human spaceflight by Bezos’ Blue Origin on......

Stocks making the biggest moves midday: Square, Biogen, DocuSign and more

CNBC
CNBC – For more and to sign up click here The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images DocuSign – Shares of the electronic signature company surged 19% after beating on the......

Stock futures decline after major averages post first positive session in three

CNBC
CNBC – For more and to sign up click here U.S stock index futures declined in overnight trading on Wednesday, eating into the major averages’ gains from the session. Futures contracts tied to the Dow Jones Industrial Average slid 31 points. S&P 500 futures dipped 0.15%, while Nasdaq 100 futures......

Stock futures flat as Reddit mania unravels, Amazon and Alphabet report strong earnings

CNBC
CNBC – For more and to sign up click here U.S. stock futures were flat in overnight trading on Tuesday, after a strong market rally as the Reddit trading mania continued to unwind. Dow futures rose 15 points. S&P 500 futures gained 0.3% and Nasdaq 100 futures rose 0.4%. Strong......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More